Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-08-02
2011-08-02
Henley, III, Raymond (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S675000
Reexamination Certificate
active
07989487
ABSTRACT:
A method for preventing, diagnosing, or treating a condition mediated by an estrogen receptor by administering to a patient in need thereof an effective amount of a compound of formula I, II, or a combination thereof: wherein R1, R3, R4, and R5 are independently selected from H, OH, and ORa; R2 is selected from H, OH, and (C═O)(C1-7)alkyl; Rais (C1-7)alkyl or (C═O)(C1-7)alkyl; or a derivative of the compound selected from N-oxide derivatives, prodrug derivatives, protected derivatives, isomers, and mixtures of isomers of the compound; or a pharmaceutically acceptable salt or solvate of the compound or the derivative. Compounds of formula I and II and pharmaceuticals compositions thereof are also presented.
REFERENCES:
patent: 2006/0094699 (2006-05-01), Kampen et al.
patent: 2006/0111366 (2006-05-01), Andersen et al.
Ai Ni
Wang Nina Ching Y.
Welsh William J.
Fox Rothschild LLP
Henley III Raymond
University of Medicine and Dentistry of New Jersey
LandOfFree
Estrogen receptor modulators and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Estrogen receptor modulators and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Estrogen receptor modulators and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2778661